ISSN: 1838-7640Theranostics
Global reach, higher impact
Theranostics 2020; 10(5):2401. doi:10.7150/thno.42848 This issue Cite
Erratum
Enhanced Blood Suspensibility and Laser-Activated Tumor-specific Drug Release of Theranostic Mesoporous Silica Nanoparticles by Functionalizing with Erythrocyte Membranes: Erratum
Jinghan Su1,2, Huiping Sun1,3, Qingshuo Meng1,2, Pengcheng Zhang1, Qi Yin1, Yaping Li1,2 
1. State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai 201203, China;
2. University of Chinese Academy of Sciences, Beijing 100049, China;
3. School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Citation:
Su J, Sun H, Meng Q, Zhang P, Yin Q, Li Y. Enhanced Blood Suspensibility and Laser-Activated Tumor-specific Drug Release of Theranostic Mesoporous Silica Nanoparticles by Functionalizing with Erythrocyte Membranes: Erratum. Theranostics 2020; 10(5):2401. doi:10.7150/thno.42848. https://www.thno.org/v10p2401.htm
Other stylesCorrected-article in Theranostics, Volume 7, 523
In the initially published version of this article, the “Heart” image of the RMSNs+Laser group in Figure 7 is wrong. The correct Figure 7 is as follow:
Figure 7
H&E staining of heart, liver, spleen and kidney (100×) at the end of the antitumor inhibition test. The black circles indicated the inflammation in the heart of the Dox-treated mice. Scale bar = 100 μm.
The corrections made in this erratum do not affect the original conclusions. The authors apologize for any inconvenience or misunderstanding that this error may have caused.
References
1. Su J, Sun H, Meng Q, Zhang P, Yin Q, Li Y. Enhanced Blood Suspensibility and Laser-Activated Tumor-specific Drug Release of Theranostic Mesoporous Silica Nanoparticles by Functionalizing with Erythrocyte Membranes. Theranostics. 2017;7(3):523-537 doi:10.7150/thno.17259
Author contact
Corresponding author: Prof. Yaping Li, State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai 201203, China. Email: ypliac.cn; Tel/Fax: +86-21-20231979.
Published 2020-1-18
Citation styles
APA
Su, J., Sun, H., Meng, Q., Zhang, P., Yin, Q., Li, Y. (2020). Enhanced Blood Suspensibility and Laser-Activated Tumor-specific Drug Release of Theranostic Mesoporous Silica Nanoparticles by Functionalizing with Erythrocyte Membranes: Erratum. Theranostics, 10(5), 2401. https://doi.org/10.7150/thno.42848.
ACS
Su, J.; Sun, H.; Meng, Q.; Zhang, P.; Yin, Q.; Li, Y. Enhanced Blood Suspensibility and Laser-Activated Tumor-specific Drug Release of Theranostic Mesoporous Silica Nanoparticles by Functionalizing with Erythrocyte Membranes: Erratum. Theranostics 2020, 10 (5), 2401. DOI: 10.7150/thno.42848.
NLM
Su J, Sun H, Meng Q, Zhang P, Yin Q, Li Y. Enhanced Blood Suspensibility and Laser-Activated Tumor-specific Drug Release of Theranostic Mesoporous Silica Nanoparticles by Functionalizing with Erythrocyte Membranes: Erratum. Theranostics 2020; 10(5):2401. doi:10.7150/thno.42848. https://www.thno.org/v10p2401.htm
CSE
Su J, Sun H, Meng Q, Zhang P, Yin Q, Li Y. 2020. Enhanced Blood Suspensibility and Laser-Activated Tumor-specific Drug Release of Theranostic Mesoporous Silica Nanoparticles by Functionalizing with Erythrocyte Membranes: Erratum. Theranostics. 10(5):2401.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.